HPV Vaccination Drive India Guide

By Deva AmmulyaSN February 27, 2026

HPV Vaccination Drive in India: A Comprehensive Guide to Cervical Cancer Prevention

HPV vaccination drive in India infographic explaining cervical cancer prevention, benefits, eligibility and vaccination guidelines for women and girls

In a landmark move for public health, the Government of India is intensifying its efforts to combat cervical cancer through a widespread HPV Vaccination Drive. Cervical cancer is the second most common cancer among women in India, accounting for a significant percentage of cancer-related deaths. However, it is also one of the most preventable cancers thanks to the Human Papillomavirus (HPV) vaccine.

This article serves as a complete guide to the HPV Vaccination Drive, covering what HPV is, why the vaccine is crucial, who should get it, the government's roadmap, and how you can participate in this life-saving initiative.

What is HPV and Why is Vaccination Important?

Understanding Human Papillomavirus (HPV)

Human Papillomavirus (HPV) is a group of more than 200 related viruses, of which at least 14 strains are high-risk and can lead to cancer. It is the most common viral infection of the reproductive tract. HPV is primarily transmitted through sexual contact, and most sexually active men and women will acquire an infection at some point in their lives.

The Link Between HPV and Cancer

Persistent infection with high-risk HPV types (especially HPV 16 and 18) is the leading cause of:

Cervical Cancer (99% of cases are linked to HPV)
Other anogenital cancers (vaginal, vulvar, anal, penile)
Oropharyngeal cancers (cancers of the back of the throat)

The Power of Prevention

The HPV vaccine is a revolutionary tool in oncology. It works by preventing the initial infection with these high-risk virus types. By getting vaccinated, individuals can reduce their risk of developing these cancers by over 90%.

The Government's HPV Vaccination Drive: Objectives and Scope

Recognizing the burden of cervical cancer, the Government of India, through the Ministry of Health and Family Welfare, has launched a nationwide HPV Vaccination Drive. This program is often integrated with the existing Universal Immunization Programme (UIP).

Primary Objectives of the Drive:

Cervical Cancer Elimination: To drastically reduce the incidence of cervical cancer, aligning with the World Health Organization's (WHO) global strategy to eliminate cervical cancer as a public health problem.
Targeting Adolescent Girls: To vaccinate the most vulnerable and effective demographic—girls aged 9 to 14 years—before they become sexually active.
Increasing Accessibility: To provide the vaccine free of cost in government institutions, especially in rural and underserved areas.
Awareness and Education: To dispel myths and misinformation surrounding the vaccine and encourage high acceptance rates.

Types of HPV Vaccines Available in India

There are three main types of HPV vaccines available globally, and India has access to them. Recently, India has also developed its own indigenous vaccine to boost availability and reduce cost.

1. Gardasil (Quadrivalent)

Manufacturer: Merck (USA)
Protects Against: HPV types 6, 11, 16, and 18.
Targets: Cervical cancer, genital warts, and anal cancer.

2. Cervarix (Bivalent)

Manufacturer: GlaxoSmithKline
Protects Against: HPV types 16 and 18.
Targets: Specifically targets the two most common cancer-causing types.

3. Cervavac (Indigenous Vaccine)

Manufacturer: Serum Institute of India (in collaboration with the Government of India and DBT-BIRAC)
Significance: This is India's first indigenous HPV vaccine. It was launched to make the vaccine affordable and accessible for the national immunization program. It targets HPV 16 and 18.

Who Should Get the HPV Vaccine? (Eligibility Criteria)

The primary target for the HPV Vaccination Drive is adolescent girls, but the vaccine is beneficial for a wider demographic.

Primary Target (Government Drive):

Girls aged 9 to 14 years: This is the ideal window. The immune response to the vaccine is strongest at this age, and it is administered before any potential exposure to the virus.
School-based Programs: The drive often utilizes schools to reach this demographic efficiently.

Catch-up Vaccination:

Girls and young women aged 15 to 26 years: Those who missed the initial window can still receive the vaccine (catch-up dose), though it requires three doses instead of two.

For Boys and Men:

· While the government drive currently focuses on girls (due to the direct burden of cervical cancer), the vaccine is licensed and available for boys/men in the private sector. Vaccinating boys helps in herd immunity and prevents HPV-related penile, anal, and oropharyngeal cancers.

Who Should NOT Take the Vaccine?

Pregnant women (it is recommended to wait until after delivery).
Individuals with a history of severe allergic reaction (anaphylaxis) to a previous vaccine dose or to any component of the vaccine.

Vaccination Schedule: How Many Doses Are Required?

The schedule depends on the age at which the first dose is given.

For Individuals Aged 9–14 Years:

2-Dose Schedule: The second dose is administered 6 to 12 months after the first dose.
This is the preferred and most cost-effective schedule.

For Individuals Aged 15 Years and Older:

3-Dose Schedule: The second dose is given 1-2 months after the first, and the third dose is given 6 months after the first.
This ensures adequate immune response in older age groups.

How to Register for the HPV Vaccination Drive

The process for getting vaccinated is being streamlined to ensure maximum coverage. Here is how you or your child can participate:

Method 1: School-Based Programs

The primary mode of delivery for the target age group (9-14 years) is through schools.
Process: Schools distribute consent forms to parents. Upon signing the consent form, the vaccination team visits the school on a pre-scheduled date to administer the dose. The vaccination is recorded in the student's health card.

Method 2: Government Health Centers (For Out-of-School Girls)

Girls who are not enrolled in school can visit their nearest Primary Health Center (PHC), Community Health Center (CHC), or District Hospital.
Process: Carry your Aadhaar card and proof of age. Register at the health center's immunization desk. The vaccine is provided free of cost under the national drive.

Method 3: Private Hospitals and Clinics

For those outside the target age group or for boys, the vaccine is available at private pediatricians and gynecologists.
Process: Book an appointment. The vaccine is available on a paid basis. Ensure you get the vaccine from a registered medical practitioner.

Benefits of the HPV Vaccine: Why You Should Not Delay

Over 90% Effective: Clinical trials and real-world data (from countries like Australia and the UK) show that the vaccine is highly effective in preventing HPV infections and precancerous lesions.
Herd Immunity: High vaccination rates protect the entire community, including those who cannot be vaccinated.
Reduces the Need for Invasive Procedures: By preventing abnormal cervical cell development, it reduces the need for colposcopies and biopsies.
Peace of Mind: It provides long-lasting protection. Studies have shown protection for at least 10 years, with models suggesting it could last a lifetime.

Side Effects and Safety Profile

The HPV vaccine has an excellent safety record. It is rigorously tested before approval. The most common side effects are mild and temporary:

Local Reactions: Pain, redness, or swelling at the injection site.
Systemic Reactions: Mild fever, headache, fatigue, or nausea.
Fainting: Adolescents may feel faint after any vaccination. It is recommended to sit or lie down for 15 minutes after the shot.

Important Note: The vaccine does not contain the live virus, so it cannot cause HPV infection or cancer.

Myths and Facts About the HPV Vaccine

Despite its benefits, vaccine hesitancy exists due to misinformation. Here are some facts to counter common myths:

Myth	Fact
The vaccine promotes promiscuity.	False. The vaccine is an anti-cancer vaccine, not a behavioral one. Studies show no link between vaccination and sexual activity.
It is not needed if you are already married.	False. If you have not been exposed to HPV 16/18, the vaccine can still protect you. However, it is most effective before exposure.
The vaccine causes infertility.	False. There is absolutely no scientific evidence linking the HPV vaccine to infertility. In fact, by preventing cervical cancer, it protects fertility.
Cervical cancer runs in my family, so the vaccine won't help.	Partially True/False. While genetics play a role, cervical cancer is primarily caused by an infection (HPV). The vaccine prevents that infection, breaking the chain.
Pap smears are enough; I don't need the vaccine.	False. A Pap smear is a screening test that detects existing abnormalities. The vaccine is a preventive measure. Both are important.

The Road to Cervical Cancer Elimination in India

The WHO has set a global target to eliminate cervical cancer by 2120, with an intermediate goal of reaching 90% HPV vaccination coverage in girls by 2030.

India's HPV Vaccination Drive is a critical step towards this goal. The introduction of the indigenous vaccine Cervavac is a game-changer, as it reduces dependency on foreign imports and lowers the cost, making the "Made in India" solution a global asset.

Future Outlook:

Expansion to Boys: There are ongoing discussions to include boys in the national immunization program in the future.
Integration with Cancer Screening: The drive is being coupled with awareness about regular cervical cancer screening (Pap smear / VIA test) for women over 30.
Digital Tracking: The government is likely to use the Co-WIN platform (used for COVID vaccination) or a similar digital app to track HPV vaccination coverage.

Conclusion

The HPV Vaccination Drive is not just a health program; it is a movement to safeguard the future of millions of girls and women in India. Cervical cancer is a preventable tragedy, and the vaccine offers a powerful shield.

If you have a daughter in the target age group, or if you are a young woman eligible for the vaccine, do not delay. Visit your nearest school health camp or government health center, get accurate information from your doctor, and take the step towards a cancer-free future. Prevention is always better than cure.

Frequently Asked Questions (FAQs)

Q1. Is the HPV vaccine free in India?

A: Yes, under the government's Universal Immunization Programme (UIP), the HPV vaccine is provided free of cost to adolescent girls (target age group) at government health centers and through school health programs.

Q2. At what age should my daughter get the HPV vaccine?

A: The ideal age is 9 to 14 years. It is recommended to get the vaccine before she becomes sexually active to ensure maximum effectiveness.

Q3. Is the HPV vaccine safe?

A: Yes, it is extremely safe. Over 270 million doses have been distributed worldwide, and it has been approved by the WHO and the Drug Controller General of India (DCGI).

Q4. Do I need a booster dose?

A: Current evidence and guidelines do not recommend a booster dose for the general population. The 2-dose or 3-dose schedule provides long-lasting protection.

Q5. Can adults get the HPV vaccine?

A: Yes, adults up to the age of 45 can get the vaccine after consulting with their doctor. However, it is most effective in younger ages. It is available on a paid basis in private hospitals.

Q6. What is the cost of the HPV vaccine in private hospitals?

A: The cost varies. The indigenous Cervavac is priced affordably (approx. ₹2,000 per dose), while Gardasil may cost between ₹3,000 to ₹4,000 per dose. Prices are subject to change.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment regarding vaccination.